Clinical Trial Update: FB101 Intervention in Women Screened to Have Vaginal Dysbiosis (Dyscover-3) [NA]

View source ↗

Summary

Dyscover-3, a completed clinical trial evaluating FB101 for vaginal flora imbalance in women, has finished its study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vaginal Flora Imbalance

Drugs mentioned

• FB101

Snippet

Sponsor: Freya Biosciences ApS | Conditions: Vaginal Flora Imbalance | NA | Status: COMPLETED